Intranasal insulin affects adenyl cyclase system in rat tissues in neonatal diabetes

Central European Journal of Biology

Volumn 7, Issue 1, 2012, Pages 33-47

  Shpakov, Alexander O ^a   Chistyakova, Oksana V ^a   Derkach, Kira V ^a   Moyseyuk, Irina V ^a   Bondareva, Vera M ^a  

^a SECHENOV INSTITUTE OF EVOLUTIONARY PHYSIOLOGY AND BIOCHEMISTRY   (Russian Federation)

Author keywords

Adenylyl cyclase signaling system; Brain; Diabetes mellitus; Gonadotropin; Insulin; Myocardium; Ovary; Somatostatin; Uterus

Indexed keywords

EID: 84155194621     PISSN: 1895104X     EISSN: 16443632     Source Type: Journal    
DOI: 10.2478/s11535-011-0089-6     Document Type: Article

References (59)

1. Chitaley K., Type 1 and Type 2 diabetic-erectile dysfunction: same diagnosis (ICD-9), different disease?, J. Sex. Med., 2009, 6(Suppl. 3), 262-268.
2. Stiles M. C., Seaquist E. R., Cerebral structural and functional changes in type 1 diabetes, Minerva Med., 2010, 101, 105-114.
3. Tabit C. E., Chung W. B., Hamburg N. M., Vita J. A., Endothelial dysfunction in diabetes mellitus: molecular mechanisms and clinical implications, Rev. Endocr. Metab. Disord., 2010, 11, 61-74.
4. Hashim S., Li Y., Anand-Srivastava M. B., G proteinlinked cell signaling and cardiovascular functions in diabetes/hyperglycemia, Cell Biochem. Biophys., 2006, 44, 51-64.
5. Muniyappa R., Montagnani M., Koh K. K., Quon M. J., Cardiovascular actions of insulin, Endocr. Rev., 2007, 28, 463-491.
6. Shpakov A. O., Kuznetsova L. A., Plesneva S. A., Gur'ianov I. A., Pertseva M. N., [Molecular causes of changes in sensitivity of adenylyl cyclase signaling system to biogenic amines in the heart muscle during experimental streptozotocin diabetes], Tsitologiia, 2005, 47, 540-548, (in Russian).
7. Shpakov A. O., Kuznetsova L. A., Plesneva S. A., Pertseva M. N., [The disturbance of the transduction of adenylyl cyclase inhibiting hormonal signal in myocardium and brain of rats with experimental type II diabetes], Tsitologiia, 2007, 49, 442-450, (in Russian).
8. Shpakov A. O., Derkach K. V., Bondareva V. M., [A decrease in the sensitivity of adenylyl cyclase and heterotrimeric G proteins to chorionic gonadotrophin and peptide hormones action in the tissues of reproductive system of rats with experimental type 2 diabetes], Biomed. Khim., 2010, 4, 258-263, (in Russian).
9. Palmer T. M., Houslay M. D., Determination of G-protein levels, ADP-ribosylation by cholera and pertussis toxins and the regulation of adenylyl cyclase activity in liver plasma membranes from lean and genetically diabetic (db/db) mice, Biochim. Biophys. Acta, 1991, 1097, 193-204.
10. Weber L. P., Macleod K. M., Influence of streptozotocin diabetes on the Alpha-1 adrenoceptor and associated G proteins in rat arteries, J. Pharmacol. Exp. Ther., 1997, 283, 1469-1478.
11. Shpakov A. O., Bondareva V. M., Chistiakova O. V., [Functional state of adenylyl cyclase signaling system in reproductive tissues of rats with experimental type 1 diabetes], Tsitologiia, 2010, 52, 177-183, (in Russian).
12. Shpakov A. O., Kuznetsova L. A., Plesneva S. A., Kolychev A. P., Bondareva V. M., Chistyakova O. V., et al., Functional defects in adenylyl cyclase signaling mechanisms of insulin and relaxin action in skeletal muscles of rat with streptozotocin type 1 diabetes, Cent. Eur. J. Biol., 2006, 1, 530-544.
13. Ovalle F., Clinical approach to the patient with diabetes mellitus and very high insulin requirements, Diabetes Res. Clin. Pract., 2010, 90, 231-242.
14. Mann D. M., Woodward M., Ye F., Krousel-Wood M., Muntner P., Trends in medication use among US adults with diabetes mellitus: glycemic control at the expense of controlling cardiovascular risk factors, Arch. Intern. Med., 2009, 169, 1718-1720.
15. Benedict C., Hallschmid M., Hatke A., Schultes B., Fehm H. L., Born J., et al., Intranasal insulin improves memory in humans, Psychoneuroendocrinology, 2004, 29, 1326-1334.
16. Stockhorst U., de Fries D., Steingrueber H. J., Scherbaum W. A., Insulin and the CNS: effects on food intake, memory, and endocrine parameters and the role of intranasal insulin administration in humans, Physiol. Behav., 2004, 83, 47-54.
17. Hemmings S. J., Spafford D., Neonatal STZ model of type II diabetes mellitus in the Fischer 344 rat: characteristics and assessment of the status of the hepatic adrenergic receptors, Int. J. Biochem. Cell Biol., 2000, 32, 905-919.
18. Blondel O., Bailbé D., Portha B., Relation of insulin deficiency to impaired insulin action in NIDDM adult rats given streptozocin as neonates, Diabetes, 1989, 38, 610-617.
19. nd, Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration, Neuroscience, 2004, 127, 481-496.
20. Baker S. P., Potter L. T., A minor component of the binding of [3H]guanyl-5′-yl imidodiphosphate to cardiac membranes associated with the activation of adenylyl cyclase, J. Biol. Chem., 1981, 256, 7925-7931.
21. Shpakov A. O., Shpakova E. A., Tarasenko I. I., Derkach K. V., Vlasov G. P., The peptides mimicking the third intracellular loop of 5-hydroxytryptamine receptors of the types 1B and 6 selectively activate G proteins and receptor-specifically inhibit serotonin signaling via the adenylyl cyclase system, Int. J. Pept. Res. Ther., 2010, 16, 95-105.
22. Salomon Y., Londos C., Rodbell M. A., Highly sensitive adenylate cyclase assay, Anal. Biochem., 1974, 58, 541-548.
23. McIntire W. E., MacCleery G., Garrison J. C., The G protein b subunit is a determinant in the coupling of Gs to the b1-adrenergic and A2a adenosine receptors, J. Biol. Chem., 2001, 276, 15801-15809.
24. Shpakov A. O., Kuznetsova L. A., Plesneva S. A., Bondareva V. M., Pertseva M. N., Functional coupling of hormone receptors with G proteins in the adenylate cyclase system of the rat muscle tissues and brain under conditions of short-term hyperglycemia, Bull. Exp. Biol. Med., 2007, 144, 684-688.
25. Li Y., Descorbeth M., Anand-Srivastava M. B., Role of oxidative stress in high glucose-induced decreased expression of Giα proteins and adenylyl cyclase signaling in vascular smooth muscle cells, Am. J. Physiol. Heart Circ. Physiol., 2008, 294, 2845-2854.
26. Bushfield M., Griffiths S. L., Murphy G. J., Pyne N. J., Knowler J. T., Milligan G., et al., Diabetes-induced alterations in the expression, functioning and phosphorylation state of the inhibitory guanine nucleotide regulatory protein Gi-2 in hepatocytes, Biochem. J., 1990, 271, 365-372.
27. Livingstone C., McLellan A. R., McGregor M. A., Wilson A., Connell J. M., Small M., et al., Altered G-protein expression and adenylate cyclase activity in platelets of non-insulin-dependent diabetic (NIDDM) male subjects, Biochim. Biophys. Acta., 1991, 1096, 127-133.
28. Caro J. F., Raju M. S., Caro M., Lynch C. J., Poulos J., Exton J. H., et al., Guanine nucleotide binding regulatory proteins in liver from obese humans with and without type II diabetes: evidence for altered "cross-talk" between the insulin receptor and Giproteins, J. Cell. Biochem., 1994, 54, 309-319.
29. Gettys T. W., Ramkumar V., Surwit R. S., Taylor I. L., Tissue-specific alterations in G protein expression in genetic versus diet-induced models of non-insulin-dependent diabetes mellitus in the mouse, Metab. Clin. Exp., 1995, 44, 771-778.
30. Hattori Y., Matsuda N., Sato A., Watanuki S., Tomioka H., Kawasaki H., et al., Predominant contribution of the G protein-mediated mechanism to NaF-induced vascular contractions in diabetic rats: association with an increased level of Gqα expression, J. Pharmacol. Exp. Ther., 2000, 292, 761-768.
31. Rodgers B. D., Bernier M., Levine M. A., Endocrine regulation of G-protein subunit production in an animal model of type 2 diabetes mellitus, J. Endocrinol., 2001, 168, 509-515.
32. Hashim S., Li Y., Nagakura A., Takeo S., Anand-Srivastava M. B., Modulation of G-protein expression and adenylyl cyclase signaling by high glucose in vascular smooth muscle, Cardiovasc. Res., 2004, 63, 709-718.
33. Griffiths S. L., Knowler J. T., Houslay M. D., Diabetes-induced changes in guanine-nucleotide-regulatory-protein mRNA detected using synthetic oligonucleotide probes, Eur. J. Biochem., 1990, 193, 367-374.
34. Lin S. L., Setya S., Johnson-Farley N. N., Cowen D. S., Differential coupling of 5-HT1 receptors to G proteins of the Gi family, Br. J. Pharmacol., 2002, 136, 1072-1078.
35. Moller L. N., Stidsen C. E., Hartmann B., Holst J. J., Somatostatin receptors, Biochim. Biophys. Acta, 2003, 1616, 1-84.
36. Robinson R., Krishnakumar A., Paulose C. S., Enhanced dopamine D1 and D2 receptor gene expression in the hippocampus of hypoglycaemic and diabetic rats, Cell. Mol. Neurobiol., 2009, 29, 365-372.
37. Kumar T. P., Antony S., Gireesh G., George N., Paulose C. S., Curcumin modulates dopaminergic receptor, CREB and phospholipase C gene expression in the cerebral cortex and cerebellum of streptozotocin induced diabetic rats, J. Biomed. Sci., 2010, http://www. jbiomedsci. com/content/17/1/43.
38. Hashim S., Liu Y. Y., Wang R., Anand-Srivastava M. B., Streptozotocin-induced diabetes impairs G-protein linked signal transduction in vascular smooth muscle, Mol. Cell. Biochem., 2002, 240, 57-65.
39. Bégin-Heick N., Liver beta-adrenergic receptors, G proteins, and adenylyl cyclase activity in obesity-diabetes syndromes, Am. J. Physiol., 1994, 266, 1664-1672.
40. Uekita K., Tobise K., Onodera S., Enhancement of the cardiac β-adrenergic system at an early diabetic state in spontaneously diabetic Chinese hamsters, Jpn. Circ. J., 1997, 61, 64-73.
41. Dinçer U. D., Bidasee K. R., Güner S., Tay A., Ozçelikay A. T., Altan V. M., The effect of diabetes on expression of β1-, β2-, and β3-adrenoreceptors in rat hearts, Diabetes, 2001, 50, 455-461.
42. Bidasee K. R., Zheng H., Shao C. H., Parbhu S. K., Rozanski G. J., Patel K. P., Exercise training initiated after the onset of diabetes preserves myocardial function: effects on expression of β-adrenoceptors, J. Appl. Physiol., 2008, 105, 907-914.
43. Lahaye S. D., Gratas-Delamarche A., Malardé L., Vincent S., Zguira M. S., Morel S. L., et al., Intense exercise training induces adaptation in expression and responsiveness of cardiac β-adrenoceptors in diabetic rats, Cardiovasc. Diabetol., 2010, http://www. cardiab. com/content/9/1/72.
44. Atkins F. L., Dowell R. T., Love S., Beta-Adrenergic receptors, adenylate cyclase activity, and cardiac dysfunction in the diabetic rat, J. Cardiovasc. Pharmacol., 1985, 7, 66-70.
45. Bilginoglu A., Cicek F. A., Ugur M., Gurdal H., Turan B., The role of gender differences in betaadrenergic receptor responsiveness of diabetic rat heart, Mol. Cell. Biochem., 2007, 305, 63-69.
46. Gando S., Hattori Y., Akaishi Y., Nishihira J., Kanno M., Impaired contractile response to beta adrenoceptor stimulation in diabetic rat hearts: alterations in β adrenoceptors-G proteinadenylate cyclase system and phospholamban phosphorylation, J. Pharmacol. Exp. Ther., 1997, 282, 475-484.
47. Stanley W. C., Dore J. J., Hall J. L., Hamilton C. D., Pizzurro R. D., Roth D. A., Diabetes reduces right atrial β-adrenergic signaling but not agonist stimulation of heart rate in swine, Can. J. Physiol. Pharmacol., 2001, 79, 346-351.
48. Daniels A., van Bilsen M., Janssen B. J., Brouns A. E., Cleutjens J. P., Roemen T. H., et al., Impaired cardiac functional reserve in type 2 diabetic db/db mice is associated with metabolic, but not structural, remodeling, Acta Physiol. (Oxf), 2010, 200, 11-22.
49. Tanaka Y., Kashiwagi A., Saeki Y., Shigeta Y., Abnormalities in cardiac α1-adrenoceptor and its signal transduction in streptozocin-induced diabetic rats, Am. J. Physiol., 1992, 263, 425-429.
50. Barber M., Kasturi B. S., Austin M. E., Patel K. P., MohanKumar S. M., MohanKumar P. S., Diabetesinduced neuroendocrine changes in rats: role of brain monoamines, insulin and leptin, Brain Res., 2003, 964, 128-135.
51. Hutchinson D. S., Summers R. J., Bengtsson T., Regulation of AMP-activated protein kinase activity by G-protein coupled receptors: potential utility in treatment of diabetes and heart disease, Pharmacol. Ther., 2008, 119, 291-310.
52. Henkin R. I., Inhaled insulin-intrapulmonary, intranasal, and other routes of administration: mechanisms of action, Nutrition, 2010, 26, 33-39.
53. Gerozissis K., Brain insulin: regulation, mechanisms of action and functions, Cell. Mol. Neurobiol., 2003, 23, 1-25.
54. Laron Z., Insulin and the brain, Arch. Physiol. Biochem., 2009, 115, 112-116.
55. Brüning J. C., Gautam D., Burks D. J., Gillette J., Schubert M., Orban P. C., et al., Role of brain insulin receptor in control of body weight and reproduction, Science, 2000, 289, 2122-2125.
56. Hallschmid M., Benedict C., Born J., Fehm H. L., Kern W., Manipulating central nervous mechanisms of food intake and body weight regulation by intranasal administration of neuropeptides in man, Physiol. Behav., 2004, 83, 55-64.
57. Biessels G. J., Deary I. J., Ryan C. M., Cognition and diabetes: a lifespan perspective, Lancet Neurol., 2008, 7, 184-190.
58. Vig P. J., Subramony S. H., D'souza D. R., Wei J., Lopez M. E., Intranasal administration of IGF-I improves behavior and Purkinje cell pathology in SCA1 mice, Brain Res. Bull., 2006, 69, 573-579.
59. Benedict C., Hallschmid M., Schmitz K., Schultes B., Ratter F., Fehm H. L., et al., Intranasal insulin improves memory in humans: superiority of insulin aspart, Neuropsychopharmacology, 2007, 32, 239-243.